Comorbidity of Axis I and II Mental Disorders With Schizophrenia and Psychotic Disorders: Findings From the National Epidemiologic Survey on Alcohol and Related Conditions

被引:56
作者
McMillan, Katherine A. [4 ]
Enns, Murray W. [1 ]
Cox, Brian James [1 ,3 ]
Sareen, Jitender [1 ,2 ]
机构
[1] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB R3T 2N2, Canada
[2] Univ Manitoba, Dept Psychiat, Res & Anxiety Serv, Winnipeg, MB R3T 2N2, Canada
[3] Univ Manitoba, Dept Psychol, Winnipeg, MB R3T 2N2, Canada
[4] Univ Regina, Dept Psychol, Regina, SK S4S 0A2, Canada
来源
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE | 2009年 / 54卷 / 07期
基金
加拿大健康研究院;
关键词
schizophrenia; epidemiology; DSM; mood; anxiety; personality; substance dependence; substance abuse; PSYCHIATRIC DIAGNOSTIC MODULES; SUBSTANCE USE; PERSONALITY-DISORDERS; ANXIETY DISORDERS; UNITED-STATES; AUDADIS-IV; COMMUNITY; PREVALENCE; DEPRESSION; ABUSE;
D O I
10.1177/070674370905400709
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: To examine the comorbidity of Axis I and II disorders within a community-based sample of adults with schizophrenia. Methods: The study was conducted using data from the National Epidemiologic Survey of Alcohol and Related Conditions. A diagnosis of schizophrenia was based on respondents' self-report that they had been diagnosed by a health professional with schizophrenia or a psychotic illness or episode (SPIE). Axis I disorders and Axis II personality disorders (PDs) were assessed using the Alcohol Use Disorders and Associated Disabilities Interview Schedule. Mental and physical quality of life were assessed using the Medical Outcomes Study Short Form 12 questionnaire. Results: The prevalence of SPIE was 0.9%. We used multiple logistic regression to examine the association between the presence and absence of SPIE in Axis I and It mental disorders. Each of the Axis I and II mental disorders examined were significantly associated with a diagnosis of SPIE after controlling for age, sex, education, marital status, and household income. Conclusions: Clinicians should be aware of the patterns and extent of psychiatric comorbidities that may exist in schizophrenia. Possible mechanisms of these associations are discussed. Can J Psychiatry. 2009;54(7):477-486.
引用
收藏
页码:477 / 486
页数:10
相关论文
共 47 条
[1]  
Addington J, 1997, J PSYCHIATR NEUROSCI, V22, P99
[2]  
[Anonymous], 2000, DIAGN STAT MAN MENT, DOI DOI 10.1176/APPI.BOOKS.9780890425787
[3]   SELF-REPORTS OF THE INTERACTION BETWEEN SUBSTANCE-ABUSE AND SCHIZOPHRENIA [J].
BAIGENT, M ;
HOLME, G ;
HAFNER, RJ .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 1995, 29 (01) :69-74
[4]   Comorbid substance use and age at onset of schizophrenia [J].
Barnes, TRE ;
Mutsatsa, SH ;
Hutton, SB ;
Watt, HC ;
Joyce, EM .
BRITISH JOURNAL OF PSYCHIATRY, 2006, 188 :237-242
[5]   Prevalence and prognosis of obsessive-compulsive phenomena in schizophrenia: A critical view [J].
Bermanzohn, PC .
PSYCHIATRIC ANNALS, 1999, 29 (09) :508-512
[6]   SCHIZOPHRENIA - LIFETIME CO-MORBIDITY IN A COMMUNITY SAMPLE [J].
BLAND, RC ;
NEWMAN, SC ;
ORN, H .
ACTA PSYCHIATRICA SCANDINAVICA, 1987, 75 (04) :383-391
[7]   Drug abuse: A significant variable in schizophrenia research [J].
Boutros, N ;
Bonnet, K ;
Mak, T .
BIOLOGICAL PSYCHIATRY, 1996, 39 (12) :1053-1054
[8]   Anxiety disorders in schizophrenia [J].
Braga, RJ ;
Petrides, G ;
Figueira, I .
COMPREHENSIVE PSYCHIATRY, 2004, 45 (06) :460-468
[9]   Anxiety disorders in outpatients with schizophrenia: prevalence and impact on the subjective quality of life [J].
Braga, RJ ;
Mendlowicz, MV ;
Marrocos, RP ;
Figueira, IL .
JOURNAL OF PSYCHIATRIC RESEARCH, 2005, 39 (04) :409-414
[10]  
Chouljian T L, 1995, Ann Clin Psychiatry, V7, P19, DOI 10.3109/10401239509149020